---
title: "FDA approves Zanvastro, the first disease-modifying drug for Alexander disease"
id: "stat-news-0-stat-ionis-wins-fda-approval-for-first-drug-for-alexander-disease-a-rare-and"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-ionis-wins-fda-approval-for-first-drug-for-alexander-disease-a-rare-and"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/03/ionis-fda-approval-zanvastro-alexander-disease/?utm_campaign=rss"
published_at: "2026-09-03T20:45:56.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# FDA approves Zanvastro, the first disease-modifying drug for Alexander disease
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-ionis-wins-fda-approval-for-first-drug-for-alexander-disease-a-rare-and
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/03/ionis-fda-approval-zanvastro-alexander-disease/?utm_campaign=rss)
- **Published At:** 2026-09-03T20:45:56.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Ionis Pharmaceuticals received FDA approval for **Zanvastro**, the first disease-modifying therapy for **Alexander disease**, a rare and often fatal neurologic disorder. - The approval covers use in both children and adults. - In the pivotal trial, patients treated with Zanvastro showed stability in **walking speed**, while the control group experienced a 33% decline in that measure. - Trial data also suggested that treating younger children may lead to improvements in motor function rather than just stabilization. - Zanvastro was described as generally safe in the trial; serious adverse events occurred more often in the control group than in treated patients. - Because Alexander disease is extraordinarily rare, Ionis used an **unusual testing approach** to evaluate the drug; specific details of that approach were not reported in the source. - The source did not report additional details such as full trial size, duration, dosing, long-term outcomes, or specific labeling and postmarketing requirements. - This approval represents the first FDA-recognized disease-modifying option for this patient population, marking a notable regulatory milestone for a very rare neurologic condition.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/03/ionis-fda-approval-zanvastro-alexander-disease/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/09/03/ionis-fda-approval-zanvastro-alexander-disease/?utm_campaign=rss) [patients](https://www.statnews.com/topic/patients/) [Physicians](https://www.statnews.com/topic/physicians/) [FDA](https://www.statnews.com/topic/fda/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Breaking News](https://www.statnews.com/category/breaking-news/) # Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder ## Alexander disease is extraordinarily rare, so Ionis took an unusual approach to testing its drug * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/09/03/ionis-fda-approval-zanvastro-alexander-disease/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/09/AP7357695644179726-645x645.jpg) Bussines Wire ![](https://www.statnews.com/wp-content/uploads/2022/01/jonathan-w-avatar-round-80x80.png) By [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) Sept. 3, 2026 West Coast Biotech & Life Sciences Reporter ![](https://www.statnews.com/wp-content/uploads/2022/01/jonathan-w-avatar-round-80x80.png) [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) 1. [](https://www.linkedin.com/in/jonathan-wosen-phd-b69172147/ "Linkedin") 2. [](https://x.com/JonathanWosen "X") jonathan.wosen@statnews.com Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Ionis Pharmaceuticals on Thursdayreceived Food and Drug Administration approval for the first disease modifying therapy for Alexander disease, a rare and deadly neurological condition. The [FDA approved](https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-alexander-disease) the drug, Zanvastro, for use in children and adultsafter a pivotal trial showed that walking speed, a common measure of motor function in neurologic disease, stayed stable in treated patients while those in the control group saw a 33% decline. Advertisement The study also contained hints that treating young children can improve motor function, not just stabilize it. Researchers found that the drug was generally safe, with serious adverse events more common in the control group than among those treated. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug development](https://www.statnews.com/topic/drug-development/), [FDA](https://www.statnews.com/topic/fda/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2022/01/jonathan-w-avatar-round-80x80.png) [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) 1. [](https://x.com/JonathanWosen "X") 2. 3. [](https://www.linkedin.com/in/jonathan-wosen-phd-b69172147/ "Linkedin") West Coast Biotech & Life Sciences Reporter 1. [](https://x.com/JonathanWosen "X") 2. 3. [](https://www.linkedin.com/in/jonathan-wosen-phd-b69172147/ "Linkedin") Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/The-Readout-Logo-Black-640x99.png) ### Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-1236946488-80x80.jpg) [Why are drug overdose deaths declining?](https://www.statnews.com/2026/09/03/drug-overdose-deaths-down-sharply-commonwealth-fund-study/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Vaccine_Hesitancy-80x80.jpg) [The pediatricians who take in vaccine-skeptical parents others won’t](https://www.statnews.com/2026/09/03/vaccine-hesitant-parents-how-pediatrician-builds-trust/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_578977705-80x80.jpeg) [Doctors groups release vaccination guidelines ahead of respiratory illness season](https://www.statnews.com/2026/09/02/vaccine-integrity-project-fall-winter-guidelines-rsv-covid-flu-shots/) 4. ![](https://www.statnews.com/wp-content/uploads/2024/05/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial](https://www.statnews.com/2026/09/02/ultragenyx-drug-angelman-syndrome-clinical-trial/) 5. ![](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Abivax has still not been acquired. What’s going on?](https://www.statnews.com/2026/09/03/abivax-acquisition-target-replimune-fda/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1240429246-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [NIH proposal to cap research grants draws mixed reception, agency says](https://www.statnews.com/2026/09/01/nih-grant-cap-proposal-researcher-feedback/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/marc-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Stanford president releases emails to rebut fraud and cover-up allegations in new book](https://www.statnews.com/2026/08/27/marc-tessier-lavigne-responds-theo-baker-book-misconduct-stanford-genentech/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_182456094-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [After a rough stretch, mRNA gets a boost — at least for now](https://www.statnews.com/2026/08/31/mrna-cancer-vaccine-intersects-politics-medicine/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-1317445583-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs](https://www.statnews.com/2026/08/28/astrazeneca-ionis-wainua-eplontersen-attr-cm-study-failure-bridgebio-alnylam/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_508908319_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A Novartis drug cut inflammation. Can it improve heart outcomes? ](https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Seattle scientists launch $95 million AI biology effort ](https://www.statnews.com/2026/09/03/biotech-news-seattle-scientists-launch-95-million-ai-biology-effort/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard September 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Abivax has still not been acquired. What’s going on? ](https://www.statnews.com/2026/09/03/abivax-acquisition-target-replimune-fda/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Lab Dish Lab Dish September 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A surprising bright spot at the FDA on regulating unproven stem cells ](https://www.statnews.com/2026/09/03/stem-cell-clinics-fda-cber-warning-letters-marketing/) By Paul Knoepfler ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech September 2, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial ](https://www.statnews.com/2026/09/02/ultragenyx-drug-angelman-syndrome-clinical-trial/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 2, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: ARPA-H funds biotechs working on custom RNA therapies ](https://www.statnews.com/2026/09/02/biotech-news-arp-h-funds-biotechs-working-on-custom-rna-therapies/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Abivax has still not been acquired. What’s going on? ](https://www.statnews.com/2026/09/03/abivax-acquisition-target-replimune-fda/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs ](https://www.statnews.com/2026/08/28/astrazeneca-ionis-wainua-eplontersen-attr-cm-study-failure-bridgebio-alnylam/) By [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: We set out to quantify U.S. academic contributions to medicines. The results stunned even us ](https://www.statnews.com/2025/06/06/us-universities-fda-approved-drugs-research-patents-orange-book/) By Kevin Gardner and Michael Kinch 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book ](https://www.statnews.com/2026/08/27/marc-tessier-lavigne-responds-theo-baker-book-misconduct-stanford-genentech/) By [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: When it c
## Related Clinical Research

- [After Ultragenyx Angelman drug failure, experts say other antisense therapies still hold promise](https://medichelpline.com/clinical-feed/stat-news-1-stat-after-failure-of-angelman-syndrome-drug-experts-see-hope-in-other.md)
- [Ultragenyx Phase 3 failure: GTX-102 shows no benefit for Angelman syndrome](https://medichelpline.com/clinical-feed/stat-news-0-stat-ultragenyx-drug-to-treat-angelman-syndrome-a-rare-disease-fails-late-stage.md)
- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.